Position
Chief Executive Officer
Company
CASI Pharmaceuticals
RockvilleManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
CASI Pharmaceuticals has announced the appointment of David Cory as Chief Executive Officer. He will lead the U.S. operations and focus on advancing CID-103, a potential treatment for autoimmune diseases.
Quick answer
CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer (July 21, 2025). CASI Pharmaceuticals is based in Rockville, Maryland, United States.
- Who is the new Chief Executive Officer at CASI Pharmaceuticals?
- CASI Pharmaceuticals named David Cory Chief Executive Officer, announced July 21, 2025.
- What did CASI Pharmaceuticals announce on July 21, 2025?
- CASI Pharmaceuticals has announced the appointment of David Cory as Chief Executive Officer. He will lead the U.S. operations and focus on advancing CID-103, a potential treatment for autoimmune diseases.
- What does CASI Pharmaceuticals do?
- CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world.
- Where is CASI Pharmaceuticals based?
- CASI Pharmaceuticals is based in Rockville, Maryland, United States.
- Which similar companies made leadership changes around the same time?
- Jazz Pharmaceuticals plc (July 10, 2025), MacroGenics (August 13, 2025), ISOThrive (July 2, 2025) and Cantargia AB (August 18, 2025) also announced leadership changes within 45 days of CASI Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jazz Pharmaceuticals Appoints Renee Gala as Chief Executive Officer (July 10, 2025)
- MacroGenics Appoints Eric Risser as President and Chief Executive Officer (August 13, 2025)
- ISOThrive Inc. Appoints Mike Walther as Chief Strategy Officer (July 2, 2025)
- Cantargia Appoints Dr Hilde Steineger as Chief Executive Officer (August 18, 2025)
- OnCusp Therapeutics Appoints Dimitry S.A. Nuyten as Chief Medical Officer (June 23, 2025)
- Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer (June 19, 2025)
Who to call at CASI Pharmaceuticals, and when
A new leader at CASI Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CASI Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CASI Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CASI Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CASI Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CASI Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.